Literature DB >> 9808847

Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer.

S D Beck1, S G Lalka.   

Abstract

PURPOSE: The long-term sequelae of inferior vena caval (IVC) resection during retroperitoneal lymph node dissection for metastatic nonseminomatous germ cell testis tumor (NSGCT) were assessed.
METHODS: Between December 1973 and September 1996, 2126 of our patients underwent RPLND for retroperitoneal nodal metastases from NSGCT; 955 had bulky disease (stages B2, B3, or C) after cytoreduction chemotherapy. Of this latter group, 65 patients (6.8%) required infrarenal IVC resection during tumor excision for cure. Our protocol does not include IVC reconstruction in such cases. Indications for IVC resection included tumor encasement or encroachment, postchemotherapy desmoplastic compression, or thrombus with tumor or clot in which cavotomy and thrombectomy cannot be performed.
RESULTS: Twenty-four of the 65 patients (postoperative follow-up period range, 11 months to 16 years; median, 89 months) were alive and able to be examined or interviewed by written and/or phone survey to assess the long-term morbidity of their IVC resection. Based on the 1994 American Venous Forum International Consensus Committee reporting standards, the clinical classifications of these 24 patients were C0A (4), C3S (4), C4A (2), C4S (13), and C6A (1). Long-term disability was mild or absent in 75% of these patients.
CONCLUSION: Only 1 (4.2%) of the patients surveyed had chronic venous sequelae that would fulfill the accepted criteria for subsequent elective IVC reconstruction. Despite recent reports of IVC reconstruction demonstrating relatively good patency rates and low morbidity, the addition of such a complex, time-consuming procedure to extensive retroperitoneal lymph node dissection for metastatic NSGCT involving IVC resection is generally not necessary.

Entities:  

Mesh:

Year:  1998        PMID: 9808847     DOI: 10.1016/s0741-5214(98)70055-2

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  13 in total

1.  Tumor thrombectomy without bypass for low-grade malignant tumors extending into the inferior vena cava: report of two cases.

Authors:  Masatoshi Jibiki; Yoshinori Inoue; Norihide Sugano; Takehisa Iwai; Tomoyasu Katou
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Computerized tomography and 3-D rendering help to select surgical strategy in leiomyosarcoma of the inferior vena cava.

Authors:  Claudio S Cinà; Vincenzo Riccioli; Giuseppe Passanisi; Giuseppe Musumeci; Carla Loreto; Sergio Castorina
Journal:  Updates Surg       Date:  2013-07-26

3.  Retroperitoneal lymph node dissection for metastatic germ cell tumours.

Authors:  N Haldipur; S Devaraj; A Shehata; A K Lewis; M O Smith; M Hatton; A Nassef; J D Beard
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

4.  [Complex residual tumors after chemotherapy of nonseminomatous germ cell tumors. Laparoscopic management - limits and chances].

Authors:  S Aufderklamm; T Todenhöfer; J Hennenlotter; J Mischinger; A Sim; J Böttge; S Rausch; S Bier; O Halalsheh; A Stenzl; G Gakis; C Schwentner
Journal:  Urologe A       Date:  2015-07       Impact factor: 0.639

5.  Inferior vena cava resection with hepatectomy: challenging but justified.

Authors:  Deep J Malde; Aamir Khan; K Rajendra Prasad; Giles J Toogood; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2011-09-16       Impact factor: 3.647

Review 6.  [When is surgical resection of metastases in testicular germ cell tumors indicated and is there a scientific basis?]

Authors:  A Heidenreich; P Paffenholz; F Haidl; D Pfister
Journal:  Urologe A       Date:  2017-05       Impact factor: 0.639

7.  Surgical resection and inferior vena cava reconstruction for treatment of the malignant tumor: technical success and outcomes.

Authors:  Hitoshi Goto; Munetaka Hashimoto; Daijiro Akamatsu; Takuya Shimizu; Noriyuki Miyama; Ken Tsuchida; Yuta Tajima; Noriaki Ohuchi
Journal:  Ann Vasc Dis       Date:  2014-03-15

8.  Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.

Authors:  Axel Heidenreich; David Pfister
Journal:  Ther Adv Urol       Date:  2012-08

Review 9.  Management of Residual Mass in Germ Cell Tumors After Chemotherapy.

Authors:  Costantine Albany; Kenneth Kesler; Clint Cary
Journal:  Curr Oncol Rep       Date:  2019-01-21       Impact factor: 5.075

10.  Resection of the inferior vena cava for urological malignancies: single-center experience.

Authors:  Shuichi Kato; Toshiaki Tanaka; Hiroshi Kitamura; Naoya Masumori; Toshiro Ito; Nobuyoshi Kawaharada; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2012-09-06       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.